Clinical Trial

Exercise to Slow Cardiovascular Ageing Progression

Recruiting
View on ClinicalTrials.gov →
Summary
In ageing, deleterious alterations in cardiovascular (CV) structure and function increase risks of ageing-related cardiovascular disease (CVD). Investigators found that these CV alterations were associated with circulating serum metabolites, suggesting a metabolic basis to CV ageing. Investigators hypothesize that modification of these metabolites by intervention, such as exercise, may retard CV alterations and reduce CVD in ageing.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-03-07; most recent amendment 2025-06-03.
Status change: Not Yet Recruiting → Recruiting 2023-05-10
Trial Details
NCT Number NCT05775484
Lead Sponsor National Heart Centre Singapore
Conditions Cardiac Ageing, Exercise, Cardiovascular
Enrollment 450 participants
Start Date 2023-05-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2050-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-05